GE Healthcare and Alibaba DAMO Academy Sign Agreement to Jointly Explore "One-Scan Multi-Detection" Medical AI

Deep News
11/06

At the 8th China International Import Expo held in Shanghai, GE Healthcare and Alibaba DAMO Academy officially signed a cooperation framework agreement. The two parties aim to integrate DAMO Academy's pioneering "One-Scan Multi-Detection" medical AI technology into GE Healthcare's advanced imaging equipment, creating an integrated hardware-software solution for intelligent and precise diagnostics while accelerating its implementation.

This marks the first collaboration between Alibaba DAMO Academy and a medical equipment manufacturer, signaling its push toward large-scale adoption of "One-Scan Multi-Detection" AI. DAMO Academy has long focused on using AI to identify subtle lesions in non-contrast CT scans, achieving breakthroughs in screening for major diseases such as pancreatic cancer, gastric cancer, and aortic dissection. Its research has been published three times in the prestigious medical journal *Nature Medicine* and received the U.S. FDA's "Breakthrough Device Designation" (BDD). To date, DAMO Academy has provided medical AI services to healthcare institutions in nine countries and regions, covering over 50 million cases.

GE Healthcare operates in more than 160 countries and regions. Since introducing its first X-ray machine to China in 1897, the company has established over 30 offices, six production bases (including seven factories), and three "Innovation Centers" in Beijing, Wuxi, and Shanghai to meet the growing demand for high-quality medical services in China.

The collaboration will combine GE Healthcare's expertise in high-end medical equipment manufacturing and digital solutions with DAMO Academy's cutting-edge AI capabilities and "One-Scan Multi-Detection" technology to bridge the hardware-software gap. This integration will enable a single CT scan to detect multiple cancers, acute conditions, and chronic diseases—particularly those traditionally difficult to identify via non-contrast CT, such as gastrointestinal tumors and aortic dissection—thereby expanding diagnostic coverage while improving accuracy, efficiency, and accessibility. Moving forward, both parties will jointly optimize models, explore new methodologies, and advance productization efforts.

Sun Xuguang, Chief Technology Officer of GE Healthcare China, stated: "Leveraging years of technological expertise and industry experience, GE Healthcare has deeply integrated AI into the entire imaging chain, driving the evolution of medical imaging into the deep-learning AI era. We look forward to partnering with leading institutions like Alibaba DAMO Academy to enhance the innovation ecosystem, developing smarter, more user-friendly, and efficient integrated solutions that empower clinicians and benefit patients through precision diagnostics."

Zhang Jianfeng, Dean of Alibaba DAMO Academy, added: "Medical imaging is a key frontier for AI innovation in healthcare. Since its inception, DAMO Academy has prioritized medical AI, achieving groundbreaking progress in AI-based screening for critical diseases. We are excited to collaborate with GE Healthcare to accelerate the fusion of medical AI and high-end devices, ensuring cutting-edge technology reaches broader populations as quickly as possible."

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10